Harlem AIDS Treatment Group / Harlem Hosp Ctr
New York, New York, United States
Non-profit organization in New York City, New York
306 Malcolm X Blvd, New York, NY 10027
About Harlem AIDS Treatment Group / Harlem Hosp Ctr
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
22
Pfizer
3
City University of New York
1
Columbia University
1
Glaxo Wellcome
1
Clinical Trials at Harlem AIDS Treatment Group / Harlem Hosp Ctr
During the past decade, Harlem AIDS Treatment Group / Harlem Hosp Ctr conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1997-10-01
Completed
2,000
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Completed
300
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
1992-03-01
Completed
600
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
1995-12-01
Completed
400
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
1996-11-01
Completed
2,500
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
1994-10-01
1996-09-01
Completed
557
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
1998-10-01
Completed
525
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 22 trials, followed by "Pfizer" with 3 trials
sponsored, "City University of New York" with 1 trials sponsored, "Columbia University" with 1 trials sponsored and "Glaxo Wellcome"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Harlem AIDS Treatment Group / Harlem Hosp Ctr"
#1 collaborator was "Glaxo Wellcome" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Fujisawa Pharmaceutical Co" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Harlem AIDS Treatment Group / Harlem Hosp Ctr
According to Clinical.Site data, the most researched conditions in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" are
"HIV Infections" (26 trials), "Pneumonia, Pneumocystis Carinii" (5 trials), "Tuberculosis" (5 trials), "Meningitis, Cryptococcal" (3 trials) and "Candidiasis" (1 trials). Many other conditions were trialed in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" in a lesser frequency.
Clinical Trials Intervention Types at Harlem AIDS Treatment Group / Harlem Hosp Ctr
Most popular intervention types in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" are "Drug" (21 trials), "Behavioral" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fluconazole" (4 trials), "Amphotericin B" (3 trials), "Isoniazid" (3 trials), "Pyridoxine hydrochloride" (3 trials) and "Atovaquone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Harlem AIDS Treatment Group / Harlem Hosp Ctr
The vast majority of trials in "Harlem AIDS Treatment Group / Harlem Hosp Ctr" are
26 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Harlem AIDS Treatment Group / Harlem Hosp Ctr
Currently, there are NaN active trials in "Harlem AIDS Treatment Group / Harlem Hosp Ctr".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 26 completed trials in Harlem AIDS Treatment Group / Harlem Hosp Ctr,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Harlem AIDS Treatment Group / Harlem Hosp Ctr, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 15 trials that are defined as “Not Applicable".